We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NLCINDIA:NSENLC India Limited Analysis

Data as of 2026-03-17 - not real-time

₹257.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

NLC India Limited is trading just below its 20‑day and 50‑day simple moving averages at around ₹257, with a neutral overall trend and an RSI hovering near 50, indicating neither strong overbought nor oversold conditions. The MACD line has crossed above its signal line, generating a bullish histogram and suggesting short‑term upward momentum, while volume has been on an increasing trajectory, albeit against a backdrop of elevated 30‑day volatility (~40%).
Fundamentally, the stock appears **undervalued** – its trailing P/E of roughly 13.4 is well below the utilities sector average of 23.4, and a forward P/E near 11 underscores potential upside. The company delivers a solid 2.77% dividend yield with a modest payout ratio of about 16%, making the dividend stream **sustainable**. Margins remain robust (gross >80%, operating ~20%) despite only modest revenue growth (~0.7% YoY), and recent operational highlights include the commissioning of a 660 MW thermal unit, signaling continued expansion in both thermal and renewable capacities. However, the balance sheet is heavily leveraged, with a debt‑to‑equity ratio exceeding 100%, which tempers the long‑run risk profile.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD crossover with rising volume
  • Price near key moving averages
  • High short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued relative to sector P/E
  • Sustainable dividend yield
  • Expansion in renewable and thermal capacity

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Regulated utilities cash flow stability
  • High leverage (debt‑to‑equity >100%)
  • Long‑term growth from renewable investments

Key Metrics & Analysis

Financial Health

Revenue Growth0.70%
Profit Margin16.03%
P/E Ratio13.4
Debt/Equity104.68
P/B Ratio1.6
Industry P/E23.4

Technical Analysis

TrendNeutral
RSI50.6
Support₹236.00
Resistance₹274.85
MA 20₹257.54
MA 50₹257.66
MA 200₹248.93
MACDBullish
VolumeIncreasing
Fear & Greed Index79.45

Valuation

Target Price₹324.00
Upside/Downside26.07%
GradeUndervalued
TypeBlend
Dividend Yield2.77%

Risk Assessment

Beta0.13
Volatility39.50%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.